The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1

Molecular Pharmacology

Volumn 56, Issue 3, 1999, Pages 570-580

  Cihlar, Tomas ^a   Lin, Deborah C ^a   Pritchard, John B ^b   Fuller, Michael D ^a   Mendel, Dirk B ^a   Sweet, Douglas H ^b  

^a GILEAD SCIENCES   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; CARRIER PROTEIN; CIDOFOVIR; NUCLEOTIDE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; DNA SEQUENCE; DRUG ACCUMULATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; KIDNEY TUBULE ABSORPTION; NEPHROTOXICITY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0032856603     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.3.570     Document Type: Article

References (39)

1. Abe T, Kakyo M, Sakagami H, Tokui T, Nishio T, Tanemoto M, Nomura H, Hebert SC, Matsuno S, Kondo H and Yawo H (1998) Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J Biol Chem 273:22395-22401.
2. Barditch-Crovo P, Toole J, Hendrix CW, Cundy KC, Ebeling D, Jaffe HS and Lietman PS (1997) Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)phosphonylmethoxyethyl]adenine) in HIV-infected patients. J Infect Dis 176:406-413.
3. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ and Cooper DA (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS (London) 12:F51-F58.
4. Cihlar T and Bischofberger N (1998) PMEA and PMPA: Acyclic nucleoside phosphonates with potent anti-HIV activity, in Trends in Drug Research II (Van der Goot H ed) pp 105-116, Elsevier, Amsterdam.
5. Cihlar T, Fuller MD and Cherrington JM (1997) Expression of the catalytic subunit (UL54) and the accessory protein (UL44) of human cytomegalovirus DNA polymerase in a coupled in vitro transcription/translation system. Protein Expr Purif 11:209-218.
6. Cundy KC, Barditch-Crovo P, Walker RE, Collier AC, Ebeling D, Toole J and Jaffe HS (1995a) Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients. Antimicrob Agents Chemother 39:2401-2405.
7. Cundy KC, Petty BG, Flaherty J, Fisher PE, Polis MA, Wachsman M, Lietman PS, Lalezari JP, Hitchcock MJM and Jaffe HS (1995b) Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 39:1247-1252.
8. Cundy KC, Bidgood AM, Lynch G, Shaw JP, Griffin L and Lee WA (1996a) Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats. Drug Metab Dispos 24:745-752.
9. Cundy KC, Li ZH and Lee WA (1996b) Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits. Drug Metab Dispos 24:315-321.
10. Dalakas M, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B and Griffin JL (1990) Mitochondrial myopathy caused by long-term AZT (zidovudine) therapy: Management and differences from HIV-associated myopathy. N Engl J Med 322:1098-1105.
11. Dubinsky RM, Yarchoan R, Dalakas M and Broder S (1989) Reversible azonal neuropathy from the treatment of AIDS and related disorders with 2′,3′-dideoxycytidine (ddC). Muscle Nerve 12:856-860.
12. Fisher E, Brosgart C, Cohn D, Chaloner K, Pulling C, Scmetter B, Alston B and El-Sadr W (1999) Safety of adefovir dipivoxil (ADV) and incidence of proximal renal tubular disorder (PRTD) in a placebo-controlled trial in patients with advanced HIV disease (Abstract). 6th Conference on Retroviruses and Opportunistic Infections, Abstract no. 491, p 160; Chicago. Alexandria, VA: Foundation for Retrovirology and Human Health.
13. Hitchcock MJM, Jaffe JS, Martin JC and Stagg RJ (1996) Cidofovir, a new agent with potent anti-herpesvirus activity. Antiviral Chem Chemother 7:115-127.
14. Holy A and Rosenberg I (1987) Synthesis of 9-(2-phosphonylmethoxyethyl)adenine and related compounds. Collect Czech Chem Commun 52:2801-2809.
15. Hosoyamada M, Sekine T, Kanai Y and Endou H (1999) Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 276:F122-F128.
16. Jacquemin E, Hagenbuch B, Stieger B, Wolkoff AW and Meier PJ (1994) Expression cloning of a rat liver Na(+)-independent organic anion transporter. Proc Natl Acad Sci USA 91:133-137.
17. Kozak M (1987) An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15:8125-8148.
18. Kullak-Ublick GA, Hagenbuch B, Stieger B, Schteingart CD, Hofmann AF, Wolkoff AW and Meier PJ (1995) Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 109: 1274-1282.
19. Kyte J and Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105-132.
20. Lacy SA, Hitchcock MJM, Lee WA, Taylor A, Eisenberg G and Cundy KC (1998a) Evaluation of toxicity associated with chronic administration of anti-HIV nucleotide analogue adefovir dipivoxil in rats and cynomolgus monkeys (Abstract). Society of Toxicology Meeting, Abstract no. 1844, p 283; Seattle. Reston, VA: Society of Toxicology.
21. Lacy SA, Hitchcock MJM, Lee WA, Tellier P and Cundy KC (1998b) Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys. Toxicol Sci 4:97-106.
22. Lalezari JP, Stagg RJ, Kuppermann BD, Holland GN, Kramer F, Ives DV, Youle M, Robinson MR, Drew WL and Jaffe HS (1997) Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: A randomized, controlled trial. Ann Intern Med 126:257-263.
23. Lopez-Nieto CE, You G, Bush KT, Barros EJ, Beier DR and Nigam SK (1997) Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J Biol Chem 272:6471-6478.
24. Lu R, Chan BS and Schuster VL (1999) Cloning of the human kidney PAH transporter: Narrow substrate specificity and regulation by protein kinase C. Am J Physiol 278:F295-F303.
25. Miller TB and Ross CR (1976) Transport of organic cations and anions by choroid plexus. J Pharmacol Exp Ther 196:771-777.
26. Pritchard JB (1988) Coupled transport of p-aminohippurate by rat kidney basolateral membrane vesicles. Am J Physiol 255:F597-F604.
27. Pritchard JB (1990) Rat renal cortical slices demonstrate p-aminohippurate/ glutarate exchange and sodium/glutarate coupled p-aminohippurate transport. J Pharmacol Exp Ther 255:969-975.
28. Pritchard JB and Miller DS (1993) Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 73:765-796.
29. Reid G, Wolff NA, Dautzenberg FM and Burckhardt G (1998) Cloning of a human renal p-aminohippurate transporter, hROAT1. Kidney Blood Press Res 21:233-237.
30. Roch-Ramel F, Guisan B and Schild L (1996) Indirect coupling of urate and p-aminohippurate transport to sodium in human brush-border membrane vesicles. Am J Physiol 270:F61-F68.
31. Roch-Ramel F (1998) Renal transport of organic anions. Curr Opin Nephrol Hypertens 7:517-524.
32. Saito H, Masuda S and Inui K (1996) Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney. J Biol Chem 271:20719-20725.
33. Schaub TP, Kartenbeck J, Konig J, Vogel O, Witzgall R, Kriz W and Keppler D (1997) Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol 8:1213-1221.
34. Sekine T, Watanabe N, Hosoyamada M, Kanai Y and Endou H (1997) Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272:18526-18529.
35. Sekine T, Cha SH, Tsuda M, Apiwattanakul N, Nakajima Y and Endou H (1998) Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 429:179-182.
36. Shpun S, Evans KK and Dantzler WH (1995) Interaction of alpha-KG with basolateral organic anion transporter in isolated rabbit renal S3 proximal tubules. Am J Physiol 268:F1109-F1116.
37. Sweet DH, Wolff NA and Pritchard JB (1997) Expression cloning and characterization of ROAT1, the basolateral organic anion transporter in rat kidney. J Biol Chem 272:30088-30095.
38. Tune BM (1997) Nephrotoxicity of beta-lactam antibiotics: Mechanisms and strategies for prevention. Pediatr Nephrol 11:768-772.
39. Wolff NA, Werner A, Burkhardt S and Burckhardt G (1997) Expression cloning and characterization of a renal organic anion transporter from winter flounder. FEBS Lett 417:287-291.